Baron Partners Fund Institutional Shares
$297.29+$2.47 (+0.84%)
Baron Partners Fund Institutional Shares’s quoted price sits in the upper half of its reported 52-week range, 4.9% below the high.
NASDAQ · TLLIX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:07 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Nuveen Lifecycle Index 2050 Fund R6’s quoted price sits in the upper half of its reported 52-week range, 2.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Nuveen Lifecycle Index 2050 Fund R6’s forward annual dividend is $1.15 per share, paid annual. The forward yield is 2.8% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This portfolio functions as a "fund of funds," primarily directing its investments into other underlying vehicles. It allocates capital chiefly to Class W shares of funds managed by the same Trust, though it retains the flexibility to invest in other investment pools or products. A fundamental policy requires that at least 80% of its total assets (including any borrowed capital for investment purposes) be committed to underlying funds that aim to replicate the performance of specific market indices. Currently, the advisors anticipate channeling approximately 90.50% of the fund's holdings into equity-oriented underlying funds, with the remaining 9.50% directed towards fixed-income underlying funds.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:49 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$297.29+$2.47 (+0.84%)
Baron Partners Fund Institutional Shares’s quoted price sits in the upper half of its reported 52-week range, 4.9% below the high.
$36.84-$0.03 (-0.08%)
Nuveen Lifecycle Index 2040 R6’s quoted price sits in the upper half of its reported 52-week range, 2.1% below the high.
$32.74-$0.02 (-0.06%)
Nuveen Lifecycle Index 2035 R6’s quoted price sits in the upper half of its reported 52-week range, 1.92% below the high.
$110.05+$0.38 (+0.35%)
Oakmark Select Fund Investor Class’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
$49.19+$0.49 (+1.01%)
T. Rowe Price Integrated US Sm Gr Eq Adv’s quoted price sits in the upper half of its reported 52-week range, 7.69% below the high.
$60.14+$0.66 (+1.11%)
T. Rowe Price Small-Cap Stock Fund Advisor Class’s quoted price sits in the lower half of its reported 52-week range, 10.06% below the high.
$13.20+$0.10 (+0.76%)
Nomura Value Fund Class A’s quoted price sits in the lower half of its reported 52-week range, 12.12% below the high.
$61.27-$0.13 (-0.21%)
MFS Research Fund Class A’s quoted price sits in the upper half of its reported 52-week range, 6.2% below the high.